Correlation Between Quoin Pharmaceuticals and Dianthus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Dianthus Therapeutics, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Dianthus Therapeutics.

Diversification Opportunities for Quoin Pharmaceuticals and Dianthus Therapeutics

0.23

Correlation Coefficient

Quoin Pharmaceuticals  Dianthus Therapeutics

Modest diversification

The 3 months correlation between Quoin and Dianthus is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Dianthus Therapeutics

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Dianthus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Quoin Pharmaceuticals Ltd is 1.42 times less risky than Dianthus Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Dianthus Therapeutics is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  2,828  in Dianthus Therapeutics on September 4, 2024 and sell it today you would lose (258.00) from holding Dianthus Therapeutics or give up 9.12% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Quoin Pharmaceuticals Ltd  vs.  Dianthus Therapeutics

Quoin Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly conflicting basic indicators, Quoin Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Quoin Pharmaceuticals and Dianthus Therapeutics

The main advantage of trading using opposite Quoin Pharmaceuticals and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.

The idea behind Quoin Pharmaceuticals Ltd and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.